Former President Joe Biden has been diagnosed with prostate cancer that has spread to his bones, according to CBS News. Biden is 83 years old. Bone metastases from prostate cancer represent a Stage IV (metastatic) classification under standard oncology staging systems — the most advanced stage, indicating the cancer has spread beyond the prostate to other parts of the body. The diagnosis comes approximately seven months after Biden ended his 2024 re-election campaign and approximately a year after he left office. Trump, former President Obama, and numerous political figures across partisan lines have offered statements of support.
THE MEDICAL REALITY — WHAT BONE-METASTATIC PROSTATE CANCER MEANS
ONYX covers the medical dimension accurately and without sugarcoating it. Prostate cancer with bone metastases is a serious diagnosis. The specific medical facts:
▸ Staging: prostate cancer that has spread to bones is classified as Stage IV metastatic prostate cancer — the most advanced stage
▸ Prognosis: median survival for metastatic prostate cancer (mCRPC and hormone-sensitive variants) has improved significantly in the past decade with newer treatments; five-year survival rates vary widely based on specific tumor characteristics, prior treatment history, and overall health
▸ Treatment options: hormone therapy (androgen deprivation therapy), chemotherapy, targeted agents (enzalutamide, abiraterone), bone-targeted therapy, and in some cases immunotherapy; modern treatment can manage metastatic prostate cancer as a chronic condition for extended periods
▸ Age factor: at 83, Biden’s overall health and tolerance for treatment will significantly influence which options are appropriate and effective
▸ Not a death sentence: metastatic prostate cancer at 83 does not mean imminent death; many patients live years with appropriate treatment; it does mean ongoing serious illness management
ONYX provides this medical context because accurate information about what this diagnosis means is in the public interest. Politicized minimization or dramatization of the diagnosis would both fail that standard.
THE QUESTION OF TIMING AND TRANSPARENCY
The Biden diagnosis announcement raises specific questions about the timeline of the cancer’s development relative to his public disclosures during his presidency and his campaign. Biden’s age and health were among the central concerns raised during his 2024 presidential run. Whether the cancer was present, detected, or developed during that period; whether it was disclosed appropriately if known; and what the timeline of diagnosis and disclosure actually is — these are legitimate public accountability questions that will be examined.
ONYX does not prejudge those answers. The specific timeline of diagnosis and detection is a factual question that requires Biden’s medical team’s disclosure and independent medical assessment to answer accurately. The fact that the question is being raised is appropriate; the specific answers are not yet available in confirmed form.
A former president has a serious cancer diagnosis at 83. The political response appropriately includes well-wishes across party lines. The accountability response appropriately includes questions about what was known and when.
THE POLITICAL RESPONSE
Trump, Obama, and political figures across partisan lines have issued statements expressing support for Biden and his family. This is the appropriate and consistent political response to a former president’s serious illness. The bipartisan character of the response is itself worth noting: illness, at the level of a cancer diagnosis in an 83-year-old former president, tends to produce a suspension of the normal political combat.
Whether that suspension is durable — whether questions about the timing of disclosure and what was known during Biden’s presidency become partisan political material — is a question that the next weeks will answer. For today’s coverage, ONYX presents the diagnosis, the medical context, and the political response without prejudging the accountability dimension.
WHY THIS MATTERS
Joe Biden served as the 46th President of the United States from January 2021 to January 2026. He was the oldest person ever to serve as president. His health was a persistent public debate during his term and throughout his 2024 campaign period. A prostate cancer diagnosis with bone metastases, announced after he left office, directly intersects with those prior debates about what was known, disclosed, and managed during his presidency. These questions will be examined. They should be.
WHAT HAPPENS NEXT
▸ Biden’s medical team will provide additional information on the specific cancer characteristics, treatment plan, and prognosis as appropriate
▸ The timeline of detection and disclosure will be scrutinized by medical reporters, congressional oversight, and the public
▸ Treatment decisions will be Biden’s private medical matter; any public updates will come through his office
▸ Political implications for the Democratic Party and the 2026 midterm environment will depend on how the disclosure and timeline questions resolve
| CONFIDENCE: HIGH | Biden cancer diagnosis (prostate cancer with bone metastases) is from CBS News confirmed reporting. Medical context (staging, treatment options, prognosis) is from established oncology literature. Political response (Trump, Obama, bipartisan statements) is from confirmed reporting. |
| ⚖️ BIAS CHECK — WHO IS SAYING WHAT | |
| Biden’s Office | Will release statements on his behalf; will control the medical disclosure timeline |
| Trump | Issued supportive statement; the political calculation favors magnanimity; potential accountability questions about disclosure remain separate |
| Democrats | Expressing genuine concern; will manage the disclosure timeline question carefully to avoid appearing to minimize prior health concerns |
| Medical Community | Will provide context on what bone-metastatic prostate cancer means at 83; will note both the seriousness and the treatment options |
| Press / Accountability Journalists | Will examine the timeline of detection and disclosure; this is appropriate public interest journalism |
SOURCES
▸ CBS News — Biden prostate cancer diagnosis with bone metastases, August 2026
▸ Established oncology literature — metastatic prostate cancer staging, treatment, prognosis
Q: What is the survival rate for this type of cancer?
A: Metastatic prostate cancer five-year survival rates have improved significantly with modern treatments. The American Cancer Society estimates approximately 32% five-year survival for Stage IV prostate cancer, though this varies significantly based on specific tumor characteristics, prior treatment history, and overall health. Modern targeted therapies have extended median survival substantially beyond historical benchmarks. Individual prognosis cannot be extrapolated from population statistics.
Q: Was this cancer present while Biden was president?
A: Unknown as of available reporting. Prostate cancer can be slow-growing; it may have been present for years before becoming metastatic. Whether it was detected during his presidency, what monitoring was done, and what was disclosed are the specific accountability questions the reporting will examine.
Q: Is metastatic prostate cancer curable?
A: Generally not considered curable once metastatic, but it is often manageable as a chronic condition for extended periods with modern treatment. Many patients live years with metastatic prostate cancer. The specific prognosis depends on factors that require medical assessment.
